13F

Stock

Innate Pharma S A

Ticker not mapped · held by 9 managers

Reported value

$235.5K

Holders

9

+1 new · −2 exited

Holders’ est. mark

−$86.5K

Price effect on 8 books still in the name

Largest holder

$103.9K

Lion Point Capital, LP

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Lion Point Capital, LP81.2K$103.9K−$38.1KCut−$38.1K
MORGAN STANLEY43.5K$55.7K−$20.5KCut−$25.5K
JANE STREET GROUP, LLC43.4K$55.5K−$20.4KCut−$106.8K
MILLENNIUM MANAGEMENT LLC10.1K$12.9K−$4.73KCut−$22.7K
RHUMBLINE ADVISERS4.73K$6.06K−$2.23KCut−$3.05K
UBS Group AG861$1.1K−$405Cut−$556
GAMMA Investing LLC240$307−$113Cut−$1.57K
Farther Finance Advisors, LLC10$14−$4Cut−$4
Caitong International Asset Management Co., Ltd2$3New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.